Dutta, P., Reddy, K. S., Rai, A., Madugundu, A. K., Solanki, H. S., Bhansali, A., Radotra, B. D., Kumar, N., Collier, D., Iacovazzo, D., Gupta, P., Raja, R., Gowda, H., Pandey, A., Devgun, J. S. and Korbonits, M. (2019). Surgery, octreotide, temozolomide, bevacizumab, radiotherapy, and pegvisomant treatment of an AIP mutation‒positive child. The Journal of Clinical Endocrinology and Metabolism. 104, 3539-3544. [PubMed]